Accéder au contenu
Merck

Combined posterior chamber intraocular lens, vitrectomy, Retisert, and pars plana tube in noninfectious uveitis.

Archives of ophthalmology (Chicago, Ill. : 1960) (2012-07-11)
Zaaira M Ahmad, Bret A Hughes, Gary W Abrams, Tamer H Mahmoud
RÉSUMÉ

To assess the safety and efficacy of combined cataract extraction, posterior chamber intraocular lens placement, pars plana vitrectomy, fluocinolone acetonide intravitreal implant (Retisert), and Ahmed valves with pars plana tube (CPR-PT) in eyes with chronic, posterior, noninfectious uveitis. Retrospective study of patients who underwent CPR-PT. Outcome measures included visual acuity, intraocular pressure, inflammation, and complications. Eight eyes were included, with a mean follow-up of 18 months. Mean visual acuity improved from 1.89 to 0.14 logMAR (Snellen, counting fingers at 2 ft [0.6 m]) to 20/30; P=.01). Mean intraocular pressure remained stable at 16 to 17 mm Hg (P=.35). The number of glaucoma medications per eye decreased from 2.9 to 0.25 (P=.01). Systemic prednisone therapy was discontinued in all patients by 9 months postoperatively. Inflammation was well controlled in all eyes. The CPR-PT procedure allows rapid visual rehabilitation without major short-term complications.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Fluocinolone acetonide, European Pharmacopoeia (EP) Reference Standard
Supelco
Fluocinolone acetonide, analytical standard